Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Wyeth sees its researchers awarded

Wyeth sees its researchers awarded

9th November 2007

Wyeth Pharmaceuticals, a division of Wyeth, has announced that two of its scientists have been awarded the 2007 Thomas Alva Edison Patent Award.

The Research & Development Council of New Jersey recognised the innovative work of research scientist Li Di and associate director Edward H Kerns at the Thomas Alva Edison Patent Awards ceremony in Basking Ridge, New Jersey this week.

Wyeth’s two researchers received the award on the basis of their work in developing a laboratory test to help speed the progress of new and effective treatments for central nervous system (CNS) diseases such as Alzheimer’s disease and stroke.

Parallel Artificial Membrane Permeability Assay for Blood-Brain Barrier – the technique developed by Dr Di and Mr Kerns – measures a drug candidate’s ability to pass through the blood-brain barrier.

Robert R Ruffolo Jr, president of Wyeth Research and senior vice-president at Wyeth, commented on the researchers’ developed technique.

“At Wyeth, we have a strong focus in neuroscience research, and this important development is helping to rapidly select and improve drug candidates in disease areas that traditionally have had very low treatment success rates.”

Earlier this month, Wyeth Consumer Healthcare, a division of Wyeth, announced the launch of its complete multivitamin Centrum Cadio.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.